Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20230516008
TCTR20230516008
Recruiting
Phase 4

The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis for Facial Contouring

ASTRACO MEDICAL NETWORKS LTD.0 sites39 target enrollmentMay 16, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealthy patientBipolar Radiofrequency-Assisted Lipolysis, Facial Contouring

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Healthy patient
Sponsor
ASTRACO MEDICAL NETWORKS LTD.
Enrollment
39
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 16, 2023
End Date
March 18, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
ASTRACO MEDICAL NETWORKS LTD.

Eligibility Criteria

Inclusion Criteria

  • •1\. Aged 25\-60 years
  • •2\. Both men and women
  • •3\. mild to moderate wrinkle
  • •4\. BMI 18\-29\.9

Exclusion Criteria

  • •1\. Pregnancy or lactation
  • •2\. Subject with underlying disease of coagulopathy, platelet dysfunction, cancer, immunocompromised host, epilepsy or psychiatric disease
  • •3\. Subject with cardiac pacemaker or metal equipment in body
  • •4\. current smoking or heavy alcoholism
  • •5\. Dermatitis or infection at face
  • •6\. History of anesthesia drug allergy
  • •7\. History of taking coagulopathy drug
  • •8\. History of isotretinoin or energy based deviced in 6 month before joining the research
  • •9\. History of botulinum toxin injection, filler in 12 month before joining the research
  • •10\. History of keloid

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis for cheek and nasolabial fold ContouringHealthy patientBipolar Radiofrequency-Assisted Lipolysis, Cheek and nasolabial fold Contouring
TCTR20230515001ASTRACO MEDICAL NETWORKS LTD.39
Recruiting
Phase 4
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis combined with Adjustable-depth fractional microneedle bipolar radiofrequency for periorbital RejuvenatioHealthy PatientBipolar Radiofrequency-Assisted Lipolysis,Adjustable-depth fractional microneedle bipolar radiofrequency,periorbital Rejuvenation
TCTR20230417001ASTRACO MEDICAL NETWORKS LTD.38
Completed
Phase 2
Randomized, Open Label Study of the Safety and Efficacy of BIO-11006 in the Treatment of Advanced Nonâ??Small Cell Lung Cancer.Health Condition 1: null- Advanced Nonâ??Small Cell Lung Cancer
CTRI/2018/01/011152Biomarck Pharmaceuticals60
Completed
Phase 2
To evaluate the clinical efficacy and safety of Bailing capsule in the treatment of patients with chronic kidney disease stage 2-4 (CKD stage 2-4)Stage 2 through 4 chronic kidney disease
ITMCTR2024000026Zhongda Hospital affiliated to Southeast University
Not yet recruiting
Phase 2
A clinical study to see the efficacy of bhunimbadi churna in prameha purvarupa with special reference to prediabetes.
CTRI/2024/07/070227DR Deepika Suryawanshi